JP2008526910A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526910A5
JP2008526910A5 JP2007550751A JP2007550751A JP2008526910A5 JP 2008526910 A5 JP2008526910 A5 JP 2008526910A5 JP 2007550751 A JP2007550751 A JP 2007550751A JP 2007550751 A JP2007550751 A JP 2007550751A JP 2008526910 A5 JP2008526910 A5 JP 2008526910A5
Authority
JP
Japan
Prior art keywords
mmol
acid
colorless oil
hplc
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007550751A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526910A (ja
Filing date
Publication date
Priority claimed from GBGB0500784.4A external-priority patent/GB0500784D0/en
Application filed filed Critical
Publication of JP2008526910A publication Critical patent/JP2008526910A/ja
Publication of JP2008526910A5 publication Critical patent/JP2008526910A5/ja
Pending legal-status Critical Current

Links

JP2007550751A 2005-01-14 2006-01-12 3,4,(5)−置換テトラヒドロピリジン Pending JP2008526910A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0500784.4A GB0500784D0 (en) 2005-01-14 2005-01-14 Organic compounds
PCT/EP2006/000216 WO2006074924A1 (en) 2005-01-14 2006-01-12 3,4,(5)-substituted tetrahvdropyridines

Publications (2)

Publication Number Publication Date
JP2008526910A JP2008526910A (ja) 2008-07-24
JP2008526910A5 true JP2008526910A5 (enExample) 2009-02-26

Family

ID=34224619

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007550751A Pending JP2008526910A (ja) 2005-01-14 2006-01-12 3,4,(5)−置換テトラヒドロピリジン

Country Status (12)

Country Link
US (1) US20100029647A1 (enExample)
EP (1) EP1841740A1 (enExample)
JP (1) JP2008526910A (enExample)
KR (1) KR20070094918A (enExample)
CN (1) CN101103002A (enExample)
AU (1) AU2006205877B2 (enExample)
BR (1) BRPI0606321A2 (enExample)
CA (1) CA2590898A1 (enExample)
GB (1) GB0500784D0 (enExample)
MX (1) MX2007008558A (enExample)
RU (1) RU2007130791A (enExample)
WO (1) WO2006074924A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0505969D0 (en) * 2005-03-23 2005-04-27 Novartis Ag Organic compounds
GB0514203D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
US8129411B2 (en) 2005-12-30 2012-03-06 Novartis Ag Organic compounds
EP1908471A1 (en) * 2006-10-04 2008-04-09 Speedel Experimenta AG Tetrahydropyridines as renin inhibitors
US8129538B1 (en) 2007-03-28 2012-03-06 Takeda Pharmaceutical Company Limited Renin inhibitors
CA2689109A1 (en) 2007-06-25 2008-12-31 Novartis Ag N5-(2-ethoxyethyl)-n3-(2-pyridinyl) -3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
KR101403311B1 (ko) 2008-05-05 2014-06-05 액테리온 파마슈티칼 리미티드 레닌 억제제로서의 3,4-치환된 피페리딘 유도체
US8586776B2 (en) 2009-11-05 2013-11-19 Fibrostatin, S.L. GPBP inhibition using Q2 peptidomimetics
CN103502221B (zh) 2011-03-18 2016-03-30 拜耳知识产权有限责任公司 N-(3-氨甲酰基苯基)-1h-吡唑-5-甲酰胺衍生物及其用于防治动物害虫的用途
EP2933248B1 (en) * 2012-09-14 2018-01-31 Mitsubishi Tanabe Pharma Corporation Novel renin inhibitor
WO2016114312A1 (ja) 2015-01-13 2016-07-21 日産化学工業株式会社 反応混合物中のスズ化合物の処理方法
CN110577974B (zh) * 2019-09-10 2021-07-20 杭州澳赛诺生物科技有限公司 手性3-羟基-1,2,3,6-四氢吡啶的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE242213T1 (de) * 1995-09-07 2003-06-15 Hoffmann La Roche Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
US6197959B1 (en) * 1999-04-27 2001-03-06 Hoffmann-La Roche Inc. Piperidine derivatives
EP1505945B1 (en) * 2002-05-20 2008-11-05 Bristol-Myers Squibb Company Substituted cycloalkyl p1' hepatitis c virus inhibitors
CA2490138A1 (en) * 2002-06-27 2004-01-08 Actelion Pharmaceuticals Ltd. Novel tetrahydropyridine derivatives as renin inhibitors
MXPA05011478A (es) * 2003-04-29 2005-12-12 Actelion Pharmaceuticals Ltd Derivados de 1,2,3,6-tetrahidropiridina 3,4-disustituidos novedosos.
WO2005040120A1 (en) * 2003-10-09 2005-05-06 Actelion Pharmaceuticals Ltd Tetrahydropyridine derivatives

Similar Documents

Publication Publication Date Title
ES2937236T3 (es) Derivados de dihidro-pirrolo-piridina
TWI548636B (zh) 吡咯并[2,3-d]嘧啶基、吡咯并[2,3-b]吡基及吡咯并[2,3-d]吡啶基丙烯醯胺
JP7030827B2 (ja) Ssao阻害剤として有用なアミノピリミジン化合物
US10131669B2 (en) Pyrazolopyrimidine compounds
US9120788B2 (en) Azabenzimidazole compounds
US10077269B2 (en) Imidazopyridazine compounds
KR20200083553A (ko) 치환된 피롤로피리미딘 jak 억제제 및 이의 제조 및 사용 방법
RS56807B1 (sr) Jedinjenja aminopirimidinila kao jak inhibitori
JP7057783B2 (ja) スルホニル尿素胆汁酸誘導体の調製方法
CA2811714A1 (en) Imidazotriazinone compounds
JP2008526910A5 (enExample)
US10738063B2 (en) 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
JP3268098B2 (ja) 二環性環状アミン誘導体
KR20240157703A (ko) 디-시클로프로필 기재 il-17a 조정제 및 그의 용도
JP2021528398A (ja) RORγTのモジュレーターとしての6−アミノピリジン−3−イルピラゾール
WO1997019072A1 (en) Substituted aminocycloalkylpyrrolidine derivatives
TWI570119B (zh) (2s)-3-[(3s,4s)-3-[(1r)-1-羥乙基]-4-(4-甲氧基-3-{[1-(5-甲基吡啶-2-基)吖丁啶-3-基]氧基}苯基)-3-甲基吡咯啶-1-基]-3-氧代丙烷-1,2-二醇結晶型及其用途
HK40058692A (en) 6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
HK40090317A (zh) 作为pet放射性示踪剂的[18f]-标记的咪唑幷吡啶衍生物
HK1237335A1 (en) Imidazopyridazine compounds